Clinic
Duke City Recovery Toolbox LLC
Duke City Recovery Toolbox LLC was paid $27.97M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 58% of everything it billed.
33Billing provider infoDUKE CITY RECOVERY TOOLBOX LLC
ALBUQUERQUE, NM 87102
ALBUQUERQUE, NM 87102
33aNPI1780948885assigned 07/03/2012
33bProvider typeMethadone Clinic
28Total paid$27.97M
24GClaims839,874
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Methadone Clinic providers in New Mexico
Rank by total paid#2 of 7
Median peer was paid$6.43M
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 219,494 | $4.03M | |
| 2019 | 168,536 | $3.99M | |
| 2020 | 92,367 | $4.13M | |
| 2021 | 78,181 | $3.18M | |
| 2022 | 93,785 | $3.71M | |
| 2023 | 98,609 | $4.41M | |
| 2024incomplete | 88,902 | $4.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 58% | 692,978 | 38,492 | $16.22M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 15% | 35,795 | 25,381 | $4.11M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12% | 53,353 | 35,516 | $3.48M |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 3.7% | 7,063 | 7,022 | $1.03M |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 2.2% | 7,345 | 6,857 | $626K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 2.0% | 3,968 | 3,190 | $566K |
| G0659 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes | 1.0% | 4,770 | 2,695 | $289K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.0% | 2,753 | 2,129 | $283K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 10,550 | 7,774 | $210K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 1,046 | 968 | $188K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 969 | 866 | $143K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 1,049 | 915 | $133K |
25 more codes
| 82075 | <1% | 3,353 | $123K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,579 | $89K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 567 | $86K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 283 | $63K |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 81 | $44K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,499 | $39K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,167 | $30K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 177 | $29K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 205 | $23K |
| H0001 | Alcohol and/or drug assessment | <1% | 517 | $22K |
| 86580 | <1% | 2,533 | $20K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 453 | $18K |
| 80305 | <1% | 1,359 | $16K | |
| Q3014 | Telehealth originating site facility fee | <1% | 419 | $14K |
| H0031 | Mental health assessment, by non-physician | <1% | 78 | $13K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 265 | $13K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 53 | $10K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 130 | $10K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 99 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,399 | $7K |
| 99406 | <1% | 485 | $6K | |
| 81025 | <1% | 700 | $6K | |
| 93000 | <1% | 287 | $5K | |
| 96160 | <1% | 530 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARTSFIELD, SHARON (BILLING MANAGER)